NT-proBNP and the anti-inflammatory cytokines are correlated with endothelial progenitor cells' response to cardiac surgery

Atherosclerosis

Volumn 199, Issue 1, 2008, Pages 138-146

  Cesari, Francesca ^a   Caporale, Roberto ^b   Marcucci, Rossella ^a   Caciolli, Sabina ^b   Stefano, Pier Luigi ^b   Capalbo, Andrea ^a   Macchi, Claudio ^d   Vannucci, Mauro ^c   Gensini, Gian Franco ^d   Abbate, Rosanna ^a   Gori, Anna Maria ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c Geriatric Department   (Italy)

^d IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Cardiac surgery; Cytochemokines; Endothelial progenitor cells; N terminal pro brain natriuretic peptide

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BLOOD; CARDIOVASCULAR RISK; CORONARY ARTERY BYPASS GRAFT; CORRELATION ANALYSIS; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HEART SURGERY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STEM CELL;

ACUTE-PHASE REACTION; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CORONARY ARTERY BYPASS; CYTOKINES; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 45249116984     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.09.045     Document Type: Article

References (23)

1. Insner J.M., and Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest 103 (1999) 1231-1236
2. Vasa M., Fichtlschererer S., Adler K., et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103 (2001) 2885-2890
3. Werner N., Priller J., Laufs U., et al. Bone-marrow derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol 22 (2002) 1567-1572
4. Heeschen C., Aicher A., Lehmann R., et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102 (2003) 1340-1346
5. Pistrosch F., Herbrig K., Oelschlaegel U., et al. PPARγ-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells. Atherosclerosis 185 (2005) 163-167
6. Bahlmann F., De Groot K., Mueller O., et al. Stimulation of Endothelial progenitor cells: a new putative therapeutic effect of Angiotensin II receptor antagonists. Hypertension 45 (2005) 526-529
7. Moore M.A., Hattori K., Heissig B., et al. Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1. Ann NY Acad Sci 938 (2001) 36-45
8. Hattori K., Heissig B., Tashiro K., et al. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 97 (2001) 3354-3360
9. Shomig K., Busch G., Steppich B., et al. Interleukin-8 is associated with circulating CD133+ progenitor cells in acute myocardial infarction. Eur Heart J 27 (2006) 1032-1037
10. Verma S., Kuliszewski M.A., Li S.H., et al. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 109 (2004) 2058-2067
11. Herbrig K., Haensel S., Oelschlaegel U., et al. Endothelial dysfunction in patients with rheumatoid arthritis is associated with a reduced number and impaired function of endothelial progenitor cells. Ann Rheum Dis 65 (2006) 157-163
12. + stem cells is correlated with left ventricular ejection fraction and plasma NT-proBNP levels in patients with acute myocardial infarction. Eur Heart J 27 (2006) 283-289
13. Werner N., Kosiol S., Schiegl T., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353 (2005) 999-1007
14. Gill M., Dias S., Hattori K., et al. Vascular trauma induces rapid but transient mobilization of VEGFR2+ AC133+ endothelial precursor cells. Circ Res 88 (2001) 167-174
15. Scheubel R.J., Zorn H., Silber R., et al. Age dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 42 (2003) 2073-2080
16. Roberts N., Xiao Q., Weir G., Xu Q., and Jahangiri M. Endothelial progenitor cells are mobilized after cardiac surgery. Ann Thorac Surg 83 (2007) 598-605
17. Practice guidelines for primary care physicians: 2003 ESH/ESC Hypertension guidelines. ESH/ESC hypertension guidelines committee. Hypertension 21 (2003) 1779-1786
18. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diab Care 26 (2003) 5-20
19. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adult (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
20. Romagnani P., Annunziato F., Liotta F., et al. CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res 97 (2005) 314-322
21. Dimmeler S., Aicher A., Vasa M., et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 108 (2001) 391-397
22. Tanaka T., Kanda T., Takahashi T., et al. Interleukin-6-induced reciprocal expression of SERCA and natriuretic peptides mRNA in cultured rat ventricular myocytes. J Int Med Res 32 (2004) 57-61
23. Rudiger A., Gasser S., Fischler M., et al. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Crit Care Med 34 (2006) 2140-2144